🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →
S&P 500: 762.73 -0.2% NASDAQ 100: 707.75 +0.5% Dow Jones: 534.08 -0.5%

Arrow Capital Pty - Q1 2026 13F Filings

AR

Arrow Capital Pty LTD

CIK: 0002005134
Address: Australia Sydney 88 Phillip Street Suite 28.03, Aurora Place
$99.96 M
Portfolio Value
17
Assets Held
Reporting Period: Q1 2026
Filing Status:
Active
Last Updated: 08/05/2026

Portfolio Summary (Q1 2026)

View Full Portfolio Analysis

Top Buys

Q1 2026
1. CVX Chevron Corporation
+$8.43 M
2. KMI Kinder Morgan
+$7.03 M
3. AZN Astrazeneca PLC
+$5.82 M
4. DE Deere & Company
+$5.56 M
5. SE Sea Limited
+$5.48 M

Top Sells

Q1 2026
1. WMT Walmart
−$11.69 M
2. GOOGL Alphabet
−$10.55 M
3. NVO Novo Nordisk A/S
−$9.91 M
4. C Citigroup
−$8.74 M
5. CCJ Cameco Corporation
−$8.57 M

Asset Allocation

Stocks/ETFs
-36.06%
$99.96 M 100.00%
Options
$0 0.00%
Debt
$0 0.00%
Other
$0 0.00%

Sector Allocation (Stocks)

Arrow Capital Pty Q1 2026 Filing Summary

Arrow Capital Pty LTD filed its 13F report for Q1 2026 on May 12, 2026. The portfolio totaled 99.96 M reflecting a -36.06% change from the prior quarter, spanning 17 assets. The top 10 holdings comprised 67.1% of the portfolio, with Financials as the largest sector allocation. Quarterly activity included 11 new positions and 11 complete exits.

Report Type

Status

Data Summary

Items:

Total Value:

Actions

Issuer Name Class Value Shares Option Type

FAQs for Arrow Capital Pty’s Q1 2026 Filing

Arrow Capital Pty submitted their Form 13F-HR for the Q1 2026 period on 05/12/2026. This was the only submission for the quarter.

In the Q1 2026 filing, Arrow Capital Pty reported a managed portfolio value of 99.96 M, consisting of 17 individual positions.

This page displays the raw filing documents. To see which stocks Arrow Capital Pty bought or sold during Q1 2026, please visit Arrow Capital Pty's Portfolio Analysis page.